Loading organizations...
Loading organizations...
Health Velocity Capital is a health care focused venture and growth capital partnership
Health Velocity Capital is a venture capital firm investing in growth-stage healthcare software and services companies. It deploys capital and strategic guidance to businesses enhancing healthcare affordability, sustainability, and consumer experience. The firm leverages deep industry expertise to foster innovative solutions and drive market impact.
Founded in 2017, Health Velocity Capital originated from its principals’ collective decades of experience in healthcare investing and operations. The firm's insight centered on the consistent demand for specialized capital and strategic support for companies navigating the dynamic healthcare technology sector, building directly on prior industry engagements.
The firm partners with entrepreneurs and investors, striving to be a key innovation partner. Health Velocity Capital’s mission is to generate robust financial returns while contributing to a high-quality, accessible, and patient-centered healthcare future. Its vision involves shaping the industry through focused and impactful investments.
Key people at Health Velocity Capital.
Key people at Health Velocity Capital.
# Health Velocity Capital: Transforming Healthcare Through Strategic Growth Investment
Health Velocity Capital is a San Francisco-based venture capital and private equity firm that has positioned itself as a specialized investor in the healthcare software and services sector[1][2]. Founded in 2016, the firm operates with a laser-focused investment thesis: to identify and support innovative healthcare technology companies that can drive systemic improvements in affordability, accessibility, and consumer experience across the U.S. healthcare system[2]. The firm's mission extends beyond financial returns—it seeks to catalyze a transformation toward a more sustainable, patient-centric healthcare ecosystem by backing entrepreneurs building solutions that address fundamental inefficiencies in how healthcare is delivered and consumed.
The firm's investment philosophy centers on growth-stage opportunities, with a particular emphasis on Series B through Series D rounds where companies have demonstrated product-market fit but require strategic capital and operational expertise to scale[2]. By investing exclusively in healthcare software and services businesses rather than diversifying across biotech or medical devices, Health Velocity Capital has carved out a distinct niche focused on the software-driven modernization of healthcare delivery[1]. This specialization allows the firm to develop deep domain expertise and leverage its extensive network of healthcare stakeholders—including major health plans, health systems, and technology companies representing coverage for over 175 million Americans and operation of more than 600 hospitals[2].
Health Velocity Capital operates at the intersection of venture capital and growth equity, targeting companies that can scale rapidly while improving healthcare outcomes and economics. The firm's core investment sectors include digital health platforms, healthcare software infrastructure, consumer health services, and enterprise solutions for providers and payers[1][2]. What distinguishes Health Velocity from generalist venture firms is its singular focus on healthcare innovation—the partners collectively bring over 75 years of healthcare investment experience and have been instrumental in building market-leading companies including Teladoc Health, Livongo Health, Change Healthcare, and MDLive[2].
The firm's impact on the startup ecosystem is significant in several ways. First, it provides growth-stage capital at a critical inflection point when healthcare startups need both financial resources and strategic guidance to navigate complex regulatory, reimbursement, and competitive dynamics. Second, its extensive network of Limited Partners—institutional investors, health plans, and health systems—creates unique distribution and partnership opportunities for portfolio companies that go well beyond traditional venture support. Third, by maintaining a disciplined focus on healthcare software and services, the firm has become a trusted partner to entrepreneurs building solutions in this space, effectively becoming a hub for healthcare innovation capital.
Health Velocity Capital was established in 2016, emerging during a period of accelerating digital transformation in healthcare[2][4]. The firm was founded by partners with deep roots in healthcare investing and entrepreneurship. The founding team's credibility stems from their track record of identifying and scaling transformative healthcare companies—their involvement in building Teladoc Health (a pioneer in telehealth), Livongo Health (which revolutionized chronic disease management), and Change Healthcare (a major healthcare IT infrastructure company) demonstrates their ability to recognize inflection points in healthcare technology adoption[2].
The timing of the firm's founding was strategic. By 2016, several macro trends were converging: the shift toward value-based care was accelerating, consumer demand for digital health solutions was rising, regulatory barriers to telehealth and remote monitoring were beginning to lower, and venture capital was increasingly recognizing healthcare as a sector ripe for software-driven disruption. The founders recognized that while early-stage healthcare startups had access to seed capital, there was a meaningful gap in growth-stage capital specifically tailored to healthcare companies navigating the complexities of scaling in a regulated industry. Health Velocity Capital was positioned to fill this gap by combining growth capital with healthcare domain expertise and an unparalleled network of strategic stakeholders.
Unlike generalist venture firms that spread capital across multiple sectors, Health Velocity Capital maintains an exclusive focus on healthcare software and services[1][3]. This specialization enables the firm to develop proprietary insights into market dynamics, regulatory trends, and competitive positioning that generalist investors cannot match. The firm's data-driven investment approach facilitates informed decision-making throughout the investment lifecycle, reducing the risk profile typically associated with healthcare ventures[1].
The firm's Limited Partner base is extraordinarily powerful in the healthcare context[2]. By securing commitments from major health plans, health systems, and health technology companies representing 175+ million covered lives and 600+ hospitals, Health Velocity Capital has created a unique ecosystem where portfolio companies gain immediate access to potential customers, distribution partners, and strategic acquirers. This network advantage is difficult for competitors to replicate and provides portfolio companies with tangible business development support beyond capital.
Health Velocity Capital has executed over 30 deals with a notably high exit success rate—the firm exits deals 60 percentage points more frequently than comparable venture organizations[1][4]. The firm's typical deal size ranges from $10-50 million, positioning it squarely in the growth-stage market where it can deploy meaningful capital without the dilution concerns of larger mega-rounds[4]. Notable portfolio companies include Jvion, OnShift, HealthJoy, Lemonaid Health, and Torch Dental, spanning digital health platforms, workforce management, healthcare navigation, and specialized healthcare services[4].
Beyond capital deployment, the firm leverages its partners' extensive experience across biotechnology, medical devices, and healthcare services to provide operational guidance[1]. The partners' involvement in building market-leading companies means they understand the specific challenges healthcare startups face—from navigating FDA regulations to securing payer contracts to building enterprise sales organizations. This operational support is particularly valuable for founders without prior healthcare experience.
Health Velocity Capital operates within the broader context of healthcare's digital transformation, a trend that has accelerated dramatically over the past decade. The firm is riding several powerful secular trends: the shift from fee-for-service to value-based care models, the consumerization of healthcare, the increasing adoption of artificial intelligence and machine learning in clinical and operational contexts, and the growing recognition that healthcare software and services represent a more scalable and capital-efficient path to healthcare improvement than traditional biotech or medical device development.
The timing of the firm's emergence and growth has been fortuitous. The 2016-2025 period has witnessed explosive growth in digital health adoption, driven by regulatory changes (particularly around telehealth reimbursement), technological maturation (cloud infrastructure, mobile devices, data analytics), and shifting consumer preferences. Health Velocity Capital has positioned itself at the center of this transformation, effectively becoming a key node in the healthcare innovation ecosystem.
The firm's influence extends beyond its direct portfolio. By consistently backing healthcare software and services companies, Health Velocity Capital has helped legitimize this sector as a destination for growth capital and top entrepreneurial talent. The firm's success in exiting portfolio companies at attractive valuations has demonstrated that healthcare software can generate venture-scale returns, attracting additional capital to the space and creating a virtuous cycle of innovation. Furthermore, the firm's network effects—connecting portfolio companies with health plans, health systems, and other stakeholders—have helped accelerate the adoption of innovative healthcare solutions across the industry.
Health Velocity Capital is well-positioned to remain a leading investor in healthcare software and services for the foreseeable future. The secular trends driving healthcare digital transformation show no signs of abating—if anything, they are accelerating. The convergence of artificial intelligence, advanced analytics, and healthcare data is creating new opportunities for software-driven innovation that the firm is uniquely positioned to identify and fund.
Looking ahead, several factors will likely shape the firm's evolution. First, the increasing sophistication of healthcare AI and machine learning will create new categories of investment opportunity, particularly around clinical decision support, operational optimization, and personalized medicine. Second, the ongoing consolidation of healthcare providers and payers will create both challenges and opportunities for portfolio companies seeking scale and distribution. Third, regulatory evolution—particularly around data privacy, interoperability, and AI governance in healthcare—will require the firm to maintain its deep regulatory expertise.
The firm's future influence will likely expand as healthcare continues its digital transformation. As more healthcare delivery shifts to software-mediated models, the importance of growth capital specifically tailored to healthcare companies will only increase. Health Velocity Capital's combination of specialized expertise, strategic network, and proven track record positions it to capture a disproportionate share of the most promising healthcare software opportunities. For entrepreneurs building the next generation of healthcare solutions, Health Velocity Capital represents not just capital, but a strategic partner with the network, expertise, and conviction to help transform ambitious healthcare visions into market-leading companies.
